Infant RSV Vaccine: Landmark 15,000-Baby Study Confirms Parity
A clinical breakthrough across 15,000 infants confirms that maternal vaccination and newborn monoclonal antibodies provide equal, high-level defense against seasonal RSV complications.
# Nirsevimab infant vaccine.
1 article